Association of HHV-6 and HHV-7 reactivation with the development of chronic allograft nephropathy

Journal of Clinical Virology

Volumn 46, Issue 1, 2009, Pages 29-32

  Chapenko, S ^a   Folkmane, I ^a   Ziedina, I ^a   Chistyakovs, M ^a   Rozentals, R ^a   Krumina, A ^a   Murovska, M ^a  

^a RIGA STRADINS UNIVERSITY   (Latvia)

Author keywords

Acute rejection; Chronic allograft nephropathy; Human herpesvirus 6; Human herpesvirus 7; Renal transplantation; Virus activation

Indexed keywords

BASILIXIMAB; CYCLOSPORIN A; DACLIZUMAB; GANCICLOVIR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; THYMOCYTE ANTIBODY; VIRUS DNA;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BLOOD SAMPLING; CADAVER KIDNEY; CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DOSE REDUCTION; FEMALE; GRAFT FAILURE; GRAFT INFECTION; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RESTRICTION MAPPING; TREATMENT DURATION; VIREMIA; VIRUS IDENTIFICATION; VIRUS REACTIVATION; VIRUS STRAIN;

ADULT; FEMALE; HERPESVIRUS 6, HUMAN; HERPESVIRUS 7, HUMAN; HUMANS; INCIDENCE; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; ROSEOLOVIRUS INFECTIONS; TRANSPLANTATION, HOMOLOGOUS; VIRUS ACTIVATION;

EID: 67949083519     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2009.05.018     Document Type: Article

References (31)

1. Pascual M., Theruvath T., Kawai T., Tolkoff-Rubin N., and Cosimi A.B. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 346 (2002) 580-590
2. Tong C.Y., Barkan A., Peiris J.C., Muir P., and Herrington C.S. The association of viral infection and chronic allograft nephropathy with graft dysfunction after renal transplantation. Transplantation 74 (2002) 576-578
3. Sagedal S., Hartmann A., Nordal K.P., Osnes K., Leivestad T., Foss A., et al. Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival. Kidney Int 66 (2004) 329-337
4. Nett P.C., Heisey D.M., Fernandez L.A., Sollinger H.W., and Pirsch J.D. Association of cytomegalovirus disease and acute rejection with graft loss in kidney transplantation. Transplantation 78 (2004) 1036-1041
5. Boratynska M., Banasik M., Watorek E., Patrzatek D., Szyber P., and Klinger M. Influence of cytomegalovirus disease on early and late renal graft function. Transplant Proc 38 (2006) 147-150
6. Berneman Z.N., Ablashi D.V., Li G., Eger-Fletcher M., Reitz M.S., Hung C.-L., et al. Human herpesvirus 7 is a T-lymphotropic virus and is related to, but significantly different from human herpesvirus 6 and human cytomegalovirus. Proc Natl Acad Sci USA 89 (1992) 10552-10556
7. Santoro F., Kennedy P.E., Locatelli G., Malnati M.S., Berger E.A., and Lusso P. CD46 is a cellular receptor for human herpesvirus 6. Cell 99 (1999) 817-827
8. Ablashi D.V., Blahandran N., Josephs S.F., Hung C.L., Krueger G.R.F., Kramarsky B., et al. Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates. Virology 184 (1991) 545-552
9. Boutelleau D., Duros C., Bonnafous P., Caiola D., Karras A., Castro N.D., et al. Identification of human herpesvirus 6 variants A and B by primer-specific real-time PCR may help to revisit their respective role in pathology. J Clin Virol 35 (2006) 257-263
10. Black J.B., and Pellet P.E. Human herpesvirus 7. Rev Med Virol 9 (1999) 245-262
11. Lusso P. HHV-6 and the immunosystem: mechanisms of immunomodulation and viral escape. J Clin Virol 37 Suppl. 1 (2006) 4-10
12. Osman H.K.E., Peiris J.S.M., Taylor C.E., Warwicker P., Jarret R.F., and Madeley C.R. Cytomegalovirus disease in renal allograft recipients: is human herpesvirus-7 a cofactor for disease progression?. J Med Virol 48 (1996) 295-301
13. Chapenko S., Folkmane I., Tomsone V., Amerika D., Rozentals R., and Murovska M. Co-infection of two β-herpesviruses (CMV and HHV-7) as an increased risk factor for "CMV disease" in patients undergoing renal transplantation. Clin Transplant 14 (2000) 486-492
14. Chapenko S., Folkmane I., Tomsone V., Kozireva S., Bicans J., Amerika D., et al. Infection of β-herpesviruses (CMV, HHV-6, HHV-7): role in postrenal transplantation complication. Transplant Proc 33 (2001) 2463-2464
15. Dockrell D.H., and Paya C.V. Human herpesvirus-6 and -7 in transplantation. Rev Med Virol 11 (2001) 23-36
16. Boutelliau D., Fernandez C., Andre E., Imbert-Marcille B.M., Milpied N., Agut H., et al. Human herpesvirus (HHV)-6 and HHV-7: two closely related viruses with different infection profiles in stem cell transplantation recipients. J Infect Dis 187 (2003) 179-186
17. Secchiero P., Carrigan D.R., Asano Y., Benedetti L., Crowley R.W., Komaroff A.L., et al. Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. J Infect Dis 171 (1995) 273-280
18. Studahl M., Bergstrom T., Ekeland-Sjoberg K., and Ricksten A. Detection of cytomegalovirus DNA in cerebrospinal fluid in immunocompetent patients as a sign of active infection. J Med Virol 46 (1995) 274-80.19
19. Paya C., Humar A., Dominguez E., Washburn K., Blumberg E., Alexander B., et al. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 4 (2004) 611-620
20. Varga M., Remport A., Czebe K., Peter A., Toronyi E., Fehervari I., et al. Cytomegalovirus infection after solid-organ transplantation, its risk factors, direct and indirect effects and prevention strategies. Orv Hetil 149 (2008) 551-558
21. Khoury J.A., Storch G.A., Bohl D.L., Schuessler R.M., Torrence S.M., Lockwood M., et al. Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients. Am J Transplant 6 (2006) 2134-2143
22. Hodson E.M., Craig J.C., Strippoli G.F., and Webster A.C. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst Rev 16 (2008) CD003774
23. Fishman J.A., Emery V., Freeman R., Pascual M., Rostaing L., Schlitt H.J., et al. Cytomegalovirus in transplantation-challenging the status quo. Clin Transplant 21 (2007) 149-158
24. The EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation (Part I). Nephrol Dial Transplant 15 Suppl. 7 (2000) 71-74
25. Brennan D.C., Storch G.A., Singer G.G., Lee L., Rueda J., and Schnitzler M.A. The prevalence of human herpesvirus-7 in renal transplant recipients is unaffected by oral or intravenous ganciclovir. J Infect Dis 181 (2000) 1557-1561
26. Galarraga M.C., Gomez E., de Ona M., Rodriguez A., Laures A., Boga J.A., et al. Influence of ganciclovir prophylaxis on cytomegalovirus, human herpesvirus 6, and human herpesvirus 7 viremia in renal transplant recipients. Transplant Proc 37 (2005) 2124-2126
27. Humar A., Asberg A., Kumar D., Hartmann A., Moussa G., Jardine A., et al. An assessment of herpesvirus co-infection in patients with CMV disease: correlation with clinical and virologic outcomes. Am J Transplant 9 (2009) 374-381
28. Kidd I.M., Clark D.A., Sabin C.A., Andrew D., Hassan-Walker A.F., Sweny P., et al. Prospective study of human betaherpesviruses after renal transplantation: association of human herpesvirus 7 and cytomegalovirus co-infection with cytomegalovirus disease and increased rejection. Transplantation 15 (2000) 2400-2404
29. Clark D.A. Human herpesvirus 6 and human herpesvirus 7: emerging pathogens in transplant patients. Int J Hematol 76 Suppl. 2 (2002) 246-252
30. Rasonable R.R., Brown R.A., Humar A., Covington E., Alecock E., and Paya C.V. Herpesvirus infections in solid organ transplant patients at high risk of primary cytomegalovirus disease. J Infect Dis 15 (2005) 1331-1339
31. OnoY, Ito Y., Kaneko K., Shibata-Watanabe Y., Tainaka T., Sumida W., et al. Simultaneous monitoring by real-time polymerase chain reaction of Epstein-Barr virus, human cytomegalovirus, and human herpesvirus-6 in juvenile and adult liver transplant recipients. Transplant Proc 40 (2008) 3578-3582